Filing Details
- Accession Number:
- 0000899243-20-002644
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-03 20:55:38
- Reporting Period:
- 2020-02-01
- Accepted Time:
- 2020-02-03 20:55:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727275 | William Fairey | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-01 | 8,125 | $0.00 | 8,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-02-01 | 2,899 | $68.04 | 5,226 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2020-02-01 | 8,125 | $0.00 | 8,125 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,375 | No | 4 | M | Direct |
Footnotes
- Restricted Stock Units ("RSUs") convert into common stock on a one-for-one basis.
- Represents the number of shares of Issuer's Common Stock sold to cover the Reporting Person's withholding taxes in connection with the vesting of 8,125 shares of Common Stock underlying the Reporting Person's RSUs.
- Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in four annual installments after February 1, 2019, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause after a change of control of the Issuer.
Billionaire Hedge Funds
